Capsida Biotherapeutics Alternatives & Competitors
12 companies similar to Capsida Biotherapeutics — Engineering novel AAVs and developing the next generation of gene therapies
Companies similar to Capsida Biotherapeutics
Amarna Therapeutics
Next generation gene therapy | unlocking the potential & expanding the b...
Leiden, The Netherlands
American Gene Technologies® International Inc.
Our mission is to leverage the power of gene and cell therapy to reduce human suffering fr...
Rockville, United States
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
Polymed Biopharmaceuticals
Polymed creates novel PROTAC therapies for cancers and immunology HPB-143 (IRAK4) & HPB-...
Hangzhou, China
Track all Capsida Biotherapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
AusperBio
Transforming Patient Lives For a Better Tomorrow
San Mateo, United States
Cavion
Empowering therapies for cancer and neurologic diseases through pioneering ion channel inh...
uniQure
Transforming the lives of patients through gene therapy
Amsterdam, The Netherland...
Pulmatrix Inc.
Changing medicine with a new generation of pulmonary-delivered therapeutics
Bedford, United States
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
Waltham, United States
Dyno Therapeutics
We build AI-powered gene therapies.
Watertown, United States
Anjarium Biosciences AG
DNA to Catalyze Your Advanced Therapies
Schlieren, Switzerland
Calluna Pharma
Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis a...
Oslo, Norway
About Capsida Biotherapeutics
Capsida Biotherapeutics Inc., founded in 2019, is making breakthroughs in the biotechnology and pharmaceutical industries. The company's mission, summarized by its slogan, "Engineering novel AAVs and developing the next generation of gene therapies," highlights its pioneering approach to creating targeted, non-invasive...
Developing targeted genetic medicines, Capsid engineering for disease targets, cGMP manufacturing of gene therapies, Collaborations with major biopharmaceutical companies
Patients with rare neurological and ocular diseases, Biopharmaceutical companies seeking partnerships, Healthcare professionals in genetics and neurology
Gene Therapy, AAV Engineering, Genetic Disorders, Targeted Delivery, Non-Invasive Therapies, Neurologic Diseases, Patent Portfolio, Strategic Collaborations, Translational Biology, Multimodality Cargo Development, Process Development, Biopharmaceuticals, AAV Immunology, Clinical Development
B2B, Platform, B2B2C
Licensing, Performance Based, Project Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Capsida Biotherapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Capsida Biotherapeutics on 15 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
